Diabetes risk screening

Diabetes risk screening
Type 1 diabetes is an autoimmune disease, during which the insulin-producing beta cells of the pancreas are destroyed by the body's own immune cells. Most of this process is gradual, so that the person concerned for a long time unaware of their condition. Only the complete absence of insulin production leads to serious symptoms, often with complications

go hand in hand. First-degree relatives of people with type 1 diabetes have to suffer an average of 5 percent risk itself. In the general population the risk is, however, only 0.3 percent.

To actively do "type 1 diabetes" something against the disease before the diagnosis, research, the Institute for Diabetes Research, Helmholtz Center Munich, headed by Univ.-Prof. Dr. Anette-Gabriele Ziegler, on new ways to better predictability of type 1 diabetes. To this end, the scientists use a four-car antibody test, which helps to estimate the probability of disease more accurately.

The Diabetes Research Institute provides first-degree relatives (children, siblings or parents) of type 1 diabetes from 1 to 30 Age of free to leave determine their individual risk of diabetes.

Each participant will receive a letter about the findings islet autoantibodies status and individual counseling. Depending on the state, it is advisable to check again to make the findings between 6 months and 5 years. If two or more antibodies can be detected, is for those affected if appropriate, the opportunity to participate in a prevention study by the Institute to actively prevent the possible onset of type 1 diabetes.